Pharmacists in Jbsa Ft Sam Houston, Texas


11 Pharmacists found in Jbsa Ft Sam Houston
male pharmacist

Adam B Davies, PHARM.D.


Pharmacist
3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234
210-536-6150    

male pharmacist

Brian Paul Baur, MD



3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234
210-539-5545    

female pharmacist

Bukola Fagbemi, PHARM.D.



3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234
210-916-6850    



female pharmacist

Caroline Elizabeth Conner, PHARMD


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234
210-539-9582    

male pharmacist

Dr. David Nowinski, PHARMD


Pharmacist - Oncology
3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234
210-539-1296    

female pharmacist

Demetris Bounds


Pharmacist
3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234
325-829-8287    

female pharmacist

Dr. Haniyyah Ahmad Bonvini, PHARMD, BCPS


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234
210-916-4141    

male pharmacist

Dr. Jacob Vanbemmel, PHARMD


Pharmacist
3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234
210-538-9582    

female pharmacist

Dr. Kaitlin Ann Pruskowski, PHARMD



3698 Chambers Pass, Jbsa Ft Sam Houston, TX 78234
210-916-2876    

female pharmacist

Qian Ya Lensa Tresnak, PHARMD


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234
210-808-6786    

male pharmacist

Robert S Kennedy


Pharmacist
3551 Roger Brooke Dr # Drive, Jbsa Ft Sam Houston, TX 78234
405-833-4825    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.